According to Skinbiotherapeutics latest financial reports the total liabilities of SBTX is $791.14K, an decrease of -1.68% to 2022. At the end of 2022 company had $804.69K total liabilities. This figure represents the company's financial obligations and debts, including loans, accounts payable, and other liabilities that Skinbiotherapeutics is responsible for during its operational activities.
Year | Total liabilities | Change |
---|---|---|
2023 | $791.14K | -1.68% |
2022 | $804.69K | 17.31% |
2021 | $685.97K | 70.48% |
2020 | $402.37K | 151.22% |
2019 | $160.16K | - |